{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:44:52Z","timestamp":1793119492878,"version":"4.5.0"},"reference-count":31,"publisher":"Tohoku University Medical Press","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2025]]},"DOI":"10.1620\/tjem.2025.j053","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T18:08:19Z","timestamp":1747246099000},"page":"291-298","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Value and Molecular Mechanism of MiR-411-5p in Coronary Atherosclerosis"],"prefix":"10.1620","volume":"267","author":[{"given":"Chang","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Nursing, The Affiliated Drum Tower Hospital of Nanjing University Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nursing, The Affiliated Drum Tower Hospital of Nanjing University Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghao","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Nursing, The Affiliated Drum Tower Hospital of Nanjing University Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingqi","family":"Shi","sequence":"additional","affiliation":[{"name":"Medical School of Nanjing University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Aengevaeren, V.L., Mosterd, A., Sharma, S., Prakken, N.H.J., Mohlenkamp, S., Thompson, P.D., Velthuis, B.K.&amp;Eijsvogels, T.M.H. (2020)  Exercise and Coronary Atherosclerosis: Observations, Explanations, Relevance, and Clinical Management. <i>Circulation<\/i>, 141, 1338-1350.","DOI":"10.1161\/CIRCULATIONAHA.119.044467"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Bouchareychas, L., Duong, P., Covarrubias, S., Alsop, E., Phu, T.A., Chung, A., Gomes, M., Wong, D., Meechoovet, B., Capili, A., Yamamoto, R., Nakauchi, H., McManus, M.T., Carpenter, S., Van Keuren-Jensen, K., et al.(2020)  Macrophage Exosomes Resolve Atherosclerosis by Regulating Hematopoiesis and Inflammation via MicroRNA Cargo. <i>Cell. Rep<\/i>., 32, 107881.","DOI":"10.1016\/j.celrep.2020.107881"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Ding, X., Sun, J.&amp;Zhang, X. (2022)  Circ_0076305 facilitates prostate cancer development via sponging miR-411-5p and regulating PGK1. <i>Andrologia<\/i>, 54, e14406.","DOI":"10.1111\/and.14406"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Doran, A.C., Meller, N.&amp;McNamara, C.A. (2008)  Role of smooth muscle cells in the initiation and early progression of atherosclerosis. <i>Arterioscler. Thromb. Vasc. Biol<\/i>., 28, 812-819.","DOI":"10.1161\/ATVBAHA.107.159327"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Falk, E. (2006)  Pathogenesis of atherosclerosis. <i>J. Am. Coll. Cardiol<\/i>., 47, C7-12.","DOI":"10.1016\/j.jacc.2005.09.068"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Fu, W., Liu, Z., Zhang, J., Shi, Y., Zhao, R.&amp;Zhao, H. (2020)  Effect of miR-144-5p on the proliferation, migration, invasion and apoptosis of human umbilical vein endothelial cells by targeting RICTOR and its related mechanisms. <i>Exp. Ther. Med<\/i>., 19, 1817-1823.","DOI":"10.3892\/etm.2019.8369"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Gandhi, G., Abdullah, S., Foead, A.I.&amp;Yeo, W.W.Y. (2021)  The potential role of miRNA therapies in spinal muscle atrophy. <i>J. Neurol. Sci<\/i>., 427, 117485.","DOI":"10.1016\/j.jns.2021.117485"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Jinnouchi, H., Sato, Y., Sakamoto, A., Cornelissen, A., Mori, M., Kawakami, R., Gadhoke, N.V., Kolodgie, F.D., Virmani, R.&amp;Finn, A.V. (2020)  Calcium deposition within coronary atherosclerotic lesion: Implications for plaque stability. <i>Atherosclerosis<\/i>, 306, 85-95.","DOI":"10.1016\/j.atherosclerosis.2020.05.017"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Li, H., Ouyang, X.P., Jiang, T., Zheng, X.L., He, P.P.&amp;Zhao, G.J. (2018a) MicroRNA-296: a promising target in the pathogenesis of atherosclerosis? <i>Mol. Med.<\/i>, 24, 12.","DOI":"10.1186\/s10020-018-0012-y"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Li, J., Chen, J., Zhang, F., Li, J., An, S., Cheng, M.&amp;Li, J. (2021)  LncRNA CDKN2B-AS1 hinders the proliferation and facilitates apoptosis of ox-LDL-induced vascular smooth muscle cells via the ceRNA network of CDKN2B-AS1\/miR-126-5p\/PTPN7. <i>Int. J. Cardiol<\/i>., 340, 79-87.","DOI":"10.1016\/j.ijcard.2021.08.009"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Li, S., Hao, H., Li, R.&amp;Guo, S. (2022)  Urinary Exosomal MicroRNAs as New Noninvasive Biomarkers of IgA Nephropathy. <i>Tohoku J. Exp. Med<\/i>., 256, 215-223.","DOI":"10.1620\/tjem.256.215"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Li, Y., Xiao, L., Li, J., Sun, P., Shang, L., Zhang, J., Zhao, Q., Ouyang, Y., Li, L.&amp;Gong, K. (2018b) MicroRNA profiling of diabetic atherosclerosis in a rat model. <i>Eur. J. Med. Res<\/i>., 23, 55.","DOI":"10.1186\/s40001-018-0354-5"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Lu, X., Yang, B., Yang, H., Wang, L., Li, H., Chen, S., Lu, X.&amp;Gu, D. (2022)  MicroRNA-320b Modulates Cholesterol Efflux and Atherosclerosis. <i>J. Atheroscler. Thromb<\/i>., 29, 200-220.","DOI":"10.5551\/jat.57125"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Lu, Y., Thavarajah, T., Gu, W., Cai, J.&amp;Xu, Q. (2018)  Impact of miRNA in Atherosclerosis. <i>Arterioscler. Thromb. Vasc. Biol<\/i>., 38, e159-e170.","DOI":"10.1161\/ATVBAHA.118.310227"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Meng, H., Ruan, J., Yan, Z., Chen, Y., Liu, J., Li, X.&amp;Meng, F. (2022)  New Progress in Early Diagnosis of Atherosclerosis. <i>Int. J. Mol. Sci<\/i>., 23, 8939.","DOI":"10.3390\/ijms23168939"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Nam, G.S., Kim, S., Kwon, Y.S., Kim, M.K.&amp;Nam, K.S. (2021)  A new function for MAP4K4 inhibitors during platelet aggregation and platelet-mediated clot retraction. <i>Biochem. Pharmacol<\/i>., 188, 114519.","DOI":"10.1016\/j.bcp.2021.114519"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Ouimet, M., Ediriweera, H., Afonso, M.S., Ramkhelawon, B., Singaravelu, R., Liao, X., Bandler, R.C., Rahman, K., Fisher, E.A., Rayner, K.J., Pezacki, J.P., Tabas, I.&amp;Moore, K.J. (2017)  microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis. <i>Arterioscler. Thromb. Vasc. Biol<\/i>., 37, 1058-1067.","DOI":"10.1161\/ATVBAHA.116.308916"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Sidorkiewicz, M. (2023) Is microRNA-33 an Appropriate Target in the Treatment of Atherosclerosis? <i>Nutrients<\/i>, 15, 902.","DOI":"10.3390\/nu15040902"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Toba, H., Cortez, D., Lindsey, M.L.&amp;Chilton, R.J. (2014)  Applications of miRNA technology for atherosclerosis. <i>Curr. Atheroscler. Rep<\/i>., 16, 386.","DOI":"10.1007\/s11883-013-0386-9"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Wang, J., Zhang, L., Wang, T., Li, C., Jiao, L., Zhao, Z.&amp;Li, Y. (2021)  miRNA-576 Alleviates the Malignant Progression of Atherosclerosis through Downregulating KLF5. <i>Dis. Markers<\/i>, 2021, 5450685.","DOI":"10.1155\/2021\/5450685"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Wang, P., Xu, T.Y., Guan, Y.F., Zhao, Y., Li, Z.Y., Lan, X.H., Wang, X., Yang, P.Y., Kang, Z.M., Vanhoutte, P.M.&amp;Miao, C.Y. (2014)  Vascular smooth muscle cell apoptosis is an early trigger for hypothyroid atherosclerosis. <i>Cardiovasc. Res<\/i>., 102, 448-459.","DOI":"10.1093\/cvr\/cvu056"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Wu, Y.&amp;Gunst, S.J. (2015)  Vasodilator-stimulated phosphoprotein (VASP) regulates actin polymerization and contraction in airway smooth muscle by a vinculin-dependent mechanism. <i>J. Biol. Chem<\/i>., 290, 11403-11416.","DOI":"10.1074\/jbc.M115.645788"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Wu, Y., Zhang, F., Lu, R., Feng, Y., Li, X., Zhang, S., Hou, W., Tian, J., Kong, X.&amp;Sun, L. (2020)  Functional lncRNA-miRNA-mRNA networks in rabbit carotid atherosclerosis. <i>Aging<\/i> (<i>Albany N.Y.<\/i>), 12, 2798-2813.","DOI":"10.18632\/aging.102778"},{"key":"24","unstructured":"Xia, L.H., Yan, Q.H., Sun, Q.D.&amp;Gao, Y.P. (2018)  MiR-411-5p acts as a tumor suppressor in non-small cell lung cancer through targeting PUM1. <i>Eur. Rev. Med. Pharmacol. Sci<\/i>., 22, 5546-5553."},{"key":"25","doi-asserted-by":"crossref","unstructured":"Xu, L., Fu, T., Wang, Y.&amp;Ji, N. (2023)  Diagnostic value of peripheral blood miR-296 combined with vascular endothelial growth factor B on the degree of coronary artery stenosis in patients with coronary heart disease. <i>J. Clin. Ultrasound<\/i>, 51, 520-529.","DOI":"10.1002\/jcu.23433"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Yu, T., Xu, N., Haque, N., Gao, C., Huang, W.&amp;Huang, Z. (2020)  Popular Computational Tools Used for miRNA Prediction and Their Future Development Prospects. <i>Interdiscip. Sci<\/i>., 12, 395-413.","DOI":"10.1007\/s12539-020-00387-3"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Zhang, C., Wang, H., Deng, M., He, L., Ping, F., He, Y., Fan, Z., Cheng, B.&amp;Xia, J. (2021)  Upregulated miR-411-5p levels promote lymph node metastasis by targeting RYBP in head and neck squamous cell carcinoma. <i>Int. J. Mol. Med<\/i>., 47, 36.","DOI":"10.3892\/ijmm.2021.4869"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Zhang, X., Rotllan, N., Canfran-Duque, A., Sun, J., Toczek, J., Moshnikova, A., Malik, S., Price, N.L., Araldi, E., Zhong, W., Sadeghi, M.M., Andreev, O.A., Bahal, R., Reshetnyak, Y.K., Suarez, Y., et al.(2022)  Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis Regression. <i>Circ. Res<\/i>., 131, 77-90.","DOI":"10.1161\/CIRCRESAHA.121.320296"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Xu, G., Liu, G., Ye, Y., Zhang, C., Fan, C., Wang, H., Cai, H., Xiao, R., Huang, Z.&amp;Luo, Q. (2016)  miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2. <i>Biochem. Biophys. Res. Commun<\/i>., 476, 607-613.","DOI":"10.1016\/j.bbrc.2016.06.006"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Zhang, Y.B., Guo, X.Q., Wang, G.G.&amp;Pu, H.B. (2024)  MicroRNA 98-5p Overexpression Contributes to Delayed Fracture Healing via Targeting BMP-2. <i>Tohoku J. Exp. Med<\/i>., 263, 17-25.","DOI":"10.1620\/tjem.2024.J005"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Little, P.J., Ta, H.T., Xu, S.&amp;Kamato, D. (2019)  Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease. <i>Pharmacol. Ther<\/i>., 204, 107404.","DOI":"10.1016\/j.pharmthera.2019.107404"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/267\/3\/267_2025.J053\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T03:55:50Z","timestamp":1764388550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/267\/3\/267_2025.J053\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.2025.j053","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"2025.J053"}}